COVID vaccines pushed Penn’s licensing revenue over $1 billion last year, after the school ranked No. 1 in 2021
Penn will likely be at the top again, when the bulk of its licensing revenues from COVID-19 vaccines are included in the rankings.
Skip to contentA pharmacist holds up a vial of the Moderna COVID-19 vaccine.